The Intercept was blasted by its original founder Thursday as "disgusting" after sharing a 24-minute video targeting a group of conservative journalists who have covered riots in major U.S. cities ...
The FDA turned down an Intercept Pharmaceuticals drug application for the fatty liver disease NASH, a decision that comes nearly three years after the regulator first rejected the molecule. The agency ...
On Friday, the Gastrointestinal Drugs Advisory Committee voted against the approval of OCA for treating nonalcoholic steatohepatitis (NASH). The recommendation to delay approval until additional trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback